Valuation: Futura Medical plc

Market Cap 2.37M 3.21M 2.78M 2.61M 4.46M 307M 4.53M 30.56M 11.95M 154M 12.06M 11.8M 511M P/E 2024
77.2x
P/E 2025 -0.4x
Enterprise Value -1.03M -1.4M -1.21M -1.13M -1.94M -133M -1.97M -13.27M -5.19M -66.81M -5.24M -5.12M -222M EV / Sales 2024
6,428,637x
EV / Sales 2025 1,815,433x
Free-Float
87.2%
Yield 2024 *
-
Yield 2025 -
1 day-9.33%
1 week+2.00%
Current month-2.39%
1 month+10.27%
3 months-44.11%
6 months-68.49%
Current year-63.41%
1 week 0.34
Extreme 0.34
0.5
1 month 0.3
Extreme 0.301
0.5
Current year 0.24
Extreme 0.244
1.75
1 year 0.24
Extreme 0.244
10.5
3 years 0.24
Extreme 0.244
53
5 years 0.24
Extreme 0.244
67
10 years 0.24
Extreme 0.244
95.6
Manager TitleAgeSince
Chief Executive Officer 56 2025-08-07
Director of Finance/CFO 46 2018-02-19
Chief Tech/Sci/R&D Officer 74 2016-11-15
Director TitleAgeSince
Director/Board Member 74 2016-03-31
Director/Board Member 46 2018-02-19
Chairman 69 -
Date Insider Type Main position Quantity % Market Cap.
12/8/25 Buy

Chief Financial Officer

500,000 0.1488%
12/8/25 Buy

Chief Executive Officer

5,000,000 1.4876%
12/8/25 Buy

Chief Technology Officer

500,000 0.1488%
Change 5-day change 1-year change 3-year change Capi.($)
-9.33%+2.00%-95.55%-99.19% 3.53M
-1.90%+11.59%+62.29%+102.60% 71.56B
-3.21%-3.13%+32.57%+60.59% 54.43B
-2.05%-6.65%+0.71%+451.67% 27.59B
-1.27%+9.09%+46.56%+4.13% 23.91B
+1.05%+2.08%-17.46%-12.93% 23.14B
+0.10%+7.99%+41.01%-20.48% 18.65B
+3.81%+16.28%+270.78%+488.06% 18.64B
-0.95%+2.46%+24.40%+574.22% 16.01B
+1.24%-1.84%+33.13%+138.10% 12.54B
Average -1.25%+3.92%+39.84%+168.68% 26.65B
Weighted average by Cap. -1.13%+1.72%+50.95%+159.64%

Financials

2024 2025
Net sales 13.93 18.87 16.3 15.31 26.18 1.8K 26.61 179.42 70.15 903.44 70.84 69.3 3K 1.7 2.3 1.99 1.87 3.19 219.8 3.24 21.86 8.55 110.07 8.63 8.44 365.77
Net income 1.29M 1.75M 1.51M 1.42M 2.43M 168M 2.47M 16.66M 6.51M 83.88M 6.58M 6.43M 279M -9.07M -12.29M -10.61M -9.97M -17.05M -1.18B -17.33M -117M -45.69M -588M -46.14M -45.14M -1.96B
Net Debt -6.6M -8.94M -7.72M -7.25M -12.4M -855M -12.61M -84.98M -33.23M -428M -33.55M -32.82M -1.42B -3.4M -4.61M -3.98M -3.74M -6.4M -441M -6.5M -43.83M -17.14M -221M -17.3M -16.93M -733M
Logo Futura Medical plc
Futura Medical plc is a consumer healthcare company that specializes in the development and global commercialization of sexual health products. The Company is a developer of sexual health products, including the lead product, Eroxon, and two products in development, including WSD4000 and Eroxon Intense. Eroxon is a clear gel used for the treatment of erectile dysfunction (ED) available over the counter and without prescription and addresses significant unmet needs in the ED market. Eroxon Intense provides a potential range extension of the Eroxon product and acts as an additional treatment option for men who have ED. WSD4000 is a topical treatment designed for sexual dysfunction in women. The Company has distribution partners in place in a number of major consumer markets, including Haleon in the United States, and Cooper Consumer Health in Europe.
Employees
13
Date Price Change Volume
26-08-14 GBX 0.4080 -9.33% 9,488,719
26-08-13 GBX 0.4500 -6.83% 3,993,050
26-08-12 GBX 0.4830 +41.64% 16,747,535
26-08-11 GBX 0.3410 +0.29% 5,969,487
26-08-10 GBX 0.3400 0.00% 371,635

Annual profits - Rate of surprise